Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company

Jiangsu HengRui Medicine Co., Ltd. clinical trials

The registry lists 1,057 studies whose lead sponsor is Jiangsu HengRui Medicine Co., Ltd. or one of 11 companies grouped under it. 303 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2026.

Keep track of what changes. Save the Jiangsu HengRui Medicine Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 473
Recruiting: 228
Status unknown: 154
Active, not recruiting: 74
Not yet recruiting: 71
Terminated: 42

Phase

Phase 1: 572
Phase 2: 348
Phase 3: 229
Phase 4: 7
Early Phase 1: 5

Where

China: 942
Australia: 47
United States: 16
Poland: 8
Korea, Republic of: 7
Ukraine: 5

Focus areas

Conditions Jiangsu HengRui Medicine Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,057. Browse all 1,057 →

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy ParticipantsNot yet recruitingNCT07889349Phase 1
Sponsor listed in the registry: Beijing Suncadia Pharmaceuticals Co., Ltd
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic CancerRecruitingNCT07232875Phase 3
A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung CancerNot yet recruitingNCT07896005Phase 3
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid TumorsRecruitingNCT07806058Phase 1/2
SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III StudyNot yet recruitingNCT07895992Phase 3
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast CancerNot yet recruitingNCT07894328Phase 3
A Phase II Study of SHR-2173 Injection in Patients With Myasthenia GravisRecruitingNCT07622342Phase 2
Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd
A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid TumorsRecruitingNCT06555068Phase 1/2
A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.RecruitingNCT07708441Phase 2/3
Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.
A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLCRecruitingNCT07798947Phase 2
Sponsor listed in the registry: Shanghai Hengrui Pharmaceutical Co., Ltd.
A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080Not yet recruitingNCT07876596Phase 1
Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.
A Trial of RLX-2508-102 in Healthy VolunteersNot yet recruitingNCT07873671Early Phase 1
Sponsor listed in the registry: Atridia Pty Ltd.
A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With HypertriglyceridemiaRecruitingNCT07799688Phase 2
Sponsor listed in the registry: Fujian Shengdi Pharmaceutical Co., Ltd.
An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.Not yet recruitingNCT07863167Phase 2
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid TumorsRecruitingNCT07676903Phase 1
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsNot yet recruitingNCT07739160Phase 2
Sponsor listed in the registry: Beijing Suncadia Pharmaceuticals Co., Ltd
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast CancerRecruitingNCT07024173Phase 3
Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)RecruitingNCT07286032Phase 3
A Study of SHR-2173 in Participants With Systemic Lupus ErythematosusRecruitingNCT07299422Phase 2
Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd
A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric PatientsRecruitingNCT06344091Phase 4
A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular CarcinomaNot yet recruitingNCT07691762Phase 3
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Study of HRS-4729 Injection in Participants With Type 2 DiabetesNot yet recruitingNCT07843862Phase 2
Sponsor listed in the registry: Fujian Shengdi Pharmaceutical Co., Ltd.
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel DiseaseRecruitingNCT07758101Phase 1
Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02)RecruitingNCT06618664Phase 3
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy ParticipantsRecruitingNCT07802964Phase 1
Sponsor listed in the registry: Fujian Shengdi Pharmaceutical Co., Ltd.
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple DosesNot yet recruitingNCT07841860Phase 1
Sponsor listed in the registry: Fujian Shengdi Pharmaceutical Co., Ltd.
Phase III Study of HRS-7535 for Hypertension With Overweight or ObesityRecruitingNCT07528027Phase 3
Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate CancerRecruitingNCT07711184Phase 1
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid TumorsRecruitingNCT07136142Phase 1/2
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in AdultsRecruitingNCT07746726Phase 3
A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and PharmacokineticsNot yet recruitingNCT07830199Phase 1
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Trial of SHR-7787 Injection in Patients With Advanced Solid TumorsRecruitingNCT06605222Phase 1/2
Sponsor listed in the registry: Shanghai Hengrui Pharmaceutical Co., Ltd.
A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With ObesityNot yet recruitingNCT07826364Phase 1
Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate CancerRecruitingNCT06568094Phase 1/2
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid RetentionRecruitingNCT07318103Phase 2
Sponsor listed in the registry: Fujian Shengdi Pharmaceutical Co., Ltd.
A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT07751341Phase 2
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal ImpairmentRecruitingNCT07807059Phase 1
Sponsor listed in the registry: Fujian Shengdi Pharmaceutical Co., Ltd.
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian CancerRecruitingNCT06840002Phase 1/2
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Study of SHR-4610 Injection in Patients With Advanced Solid TumorsRecruitingNCT07231211Phase 1/2
Sponsor listed in the registry: Shanghai Shengdi Pharmaceutical Co., Ltd
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With HyperlipidemiaRecruitingNCT07230730Phase 3
Sponsor listed in the registry: Beijing Suncadia Pharmaceuticals Co., Ltd
A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal CancerRecruitingNCT07676162Phase 3
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 StudyNot yet recruitingNCT07808918Phase 1
Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast CancerRecruitingNCT07679360Phase 3
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase I Study of HRS-3005 in B-cell MalignanciesRecruitingNCT07556822Phase 1
A Study of SHR-1819 Injection in Adolescents With Severe Atopic DermatitisRecruitingNCT07309055Phase 3
Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLCRecruitingNCT06844474Phase 2
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular DiseaseRecruitingNCT07551492Phase 3
Sponsor listed in the registry: Fujian Shengdi Pharmaceutical Co., Ltd.
A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate CancerRecruitingNCT07735377Phase 1
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBCRecruitingNCT07726992Phase 3
Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Clinical Study of HRS-2129 for Acute Gouty ArthritisRecruitingNCT07706777Phase 2
Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.